AG0039BQ

3543-75-7 | Bendamustine hydrochloride hydrate

AG0039BQ

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	3543-75-7
Catalog Number	AG0039BQ(AGN-PC-0RAW64)
Chemical Name	Bendamustine hydrochloride hydrate
IUPAC Name	4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid;hydrochloride
InChI	InChI=1S/C16H21Cl2N3O2.ClH/c1-20-14-6-5-12(21(9-7-17)10-8-18)11-13(14)19-15(20)3-2-4-16(22)23;/h5-6,11H,2-4,7-10H2,1H3,(H,22,23);1H
InChI Key	ZHSKUOZOLHMKEA-UHFFFAOYSA-N
MDL Number	MFCD01658758
Molecular Formula	C16H22Cl3N3O2
Molecular Weight	394.7238
NSC Number	138783
SMILES	Cl.ClCCN(C1=CC2=C(N(C(=N2)CCCC(=O)O)C)C=C1)CCCl
UNII	981Y8SX18M
Synonyms	bendamustin, bendamustine, bendamustine hydrochloride, Cytostasan, Hydrochloride, Bendamustine, IMET 3393, Ribomustin, Treanda, Zimet 3393, Bendamustine hydrochloride, 3543-75-7, Bendamustine HCl, Treanda, Ribomustin, Cytostasan, Bendamustin hydrochloride, SDX-105, IMET 3393, Treakisym, 4-(5-(Bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid hydrochloride, Bendamustine (hydrochloride), Bendeka, UNII-981Y8SX18M, CCRIS 1864, SyB L-0501, NSC 138783, SDX 105, 981Y8SX18M, Ribomustine, Levact, 4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid hydrochloride, 97832-05-8, AK-94013, Treanda (TN), 4-(5-(Bis(2-chloroethyl)amino)-1-methyl-1H-benzo-[d]imidazol-2-yl)butanoic acid hydrochloride, gamma(1-Methyl-5-bis(beta-chloraethyl)aminobenzimidazoyl-2)buttersaeurehydrochlorid [German], Bendit, 2-Benzimidazolinebutryric acid, 1-methyl-5-bis(2-chloroethyl)amino-, hydrochloride, 4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid;hydrochloride, Cytostosan, Innomustine, Symbenda, Benda, ZIMET 33/93, 4-[5-[bis(2-chloroethyl)amino]-1-methyl-benzimidazol-2-yl]butanoic acid hydrochloride, Ribomustin (TN), Bendamustine Hydrochloride Injection, 1H-Benzimidazole-2-butanoic acid, 5-[bis(2-chloroethyl)amino]-1-methyl monohydrochloride, AC1L2SBO, AC1Q3BIE, Bendamustine-Hydrochloride, Bendamustine Hydrochloride/, Inno-P08001, SCHEMBL18843, MLS006010156, C16H22Cl3N3O2, SDX-105 (Cytostasane) HCl, CHEMBL1201734, CTK3I6647, KS-00000FOM, DTXSID40188912, ZHSKUOZOLHMKEA-UHFFFAOYSA-N, BCPP000348, BCP02107, HY-B0077, Tox21_500623, 4-{5-[bis(2-chlorethyl)amino]-1-methyl-1h-benzimidazol-2-yl}butans, ABP000613, AN-664, ANW-58063, GP6515, MFCD01658758, MFCD16879055, NSC138783, s1212, AKOS015951203, AC-1619, ACN-040196, API0002176, BCP9000390, Bendamustine hydrochloride (JAN/USAN), Bendamustine hydrochloride [USAN:JAN], CCG-221927, CS-1771, LP00623, NSC-138783, SB17462, gamma(1-Methyl-5-bis(beta-chloraethyl)aminobenzimidazoyl-2)buttersaeurehydrochlorid, NCGC00261308-01, 4CA-0266, AN-34706, AS-15856, BC684636, LS-33224, SC-24142, SMR004234484, AB0017997, AB1008551, Bendamustine HCL (SDX-105, Cytostasane), TC-010264, 2-Benzimidazolinebutryric acid, hydrochloride, AM20090666, B4033, FT-0080832, FT-0650624, FT-0696296, ST24042980, SW219266-1, 2-Benzimidazolebutyric acid, monohydrochloride, D07085, WLN: T56 BN DNJ B1 C3VQ GN2G2G &GH, 543B757, 1H-Benzimidazole-2-butanoic acid, 5-(bis(2-chloroethyl)amino)-1-methyl-, monohydrochloride, 1H-Benzimidazole-2-butanoic acid,5-[bis(2-chloroethyl)amino]-1-methyl-, hydrochloride, 2-Benzimidazolebutyric acid, 5-(bis(2-chloroethyl)amino)-1-methyl-, monohydrochloride, 5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid hydrochloride, 5-[Bis(2-chloroethyl)amino]-1-methylbenzimidazole-2-butyric Acid Hydrochloride, 1H-Benzimidazole-2-butanoic acid, 5-(bis(2-chloroethyl)amino)-1-methyl-, monohydrochloride (9CI), 1H-Benzimidazole-2-butanoic acid, 5-[bis(2-chloroethyl)amino]-1-methyl-, hydrochloride (1:1), 1H-Benzimidazole-2-butanoicacid, 5-[bis(2-chloroethyl)amino]-1-methyl-, hydrochloride (1:?), 2-Benzimidazolebutyric acid, 5-(bis(2-chloroethyl)amino)-1-methyl-, monohydrochloride (8CI), Bendamustine, bendamustin, Bendamustinehydrochloride, Zimet 3393, Hydrochloride, Bendamustine, C16H21Cl2N3O2.ClH, Bendamustine hydrochloride hydrate, CID77082, AR-1G0244, C16-H21-Cl2-N3-O2.Cl-H, CS-I-00021, 3543-75-7 (HCl), R111, A10124, 1H-Benzimidazole-2-butanoic acid, monohydrochloride, D000069461, Bendamustine hydrochloride, 98%, a DNA-damaging agent - 200MG 200mg, 1-Methyl-5-bis(2-chloroethyl)amino-2-benzimidazolinebutyric acid hydrochloride, 1H-Benzimidazole-2-butanoic acid, 5-[bis(2-chloroethyl)amino]-1-methyl-, hydrochloride, 1H-Benzimidazole-2-butanoic acid, 5-[bis(2-chloroethyl)amino]-1-methyl-, monohydrochloride, 2-Benzimidazolebutyric acid, 5-[bis(2-chloroethyl)amino]-1-methyl-, monohydrochloride, 16506-27-7, 16801-03-9,

Complexity	380
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	2
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	393.078g/mol
Formal Charge	0
Heavy Atom Count	24
Hydrogen Bond Acceptor Count	4
Hydrogen Bond Donor Count	2
Isotope Atom Count	0
Molecular Weight	394.721g/mol
Monoisotopic Mass	393.078g/mol
Rotatable Bond Count	9
Topological Polar Surface Area	58.4A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class	6.1
Hazard statements	H317-H319
Packing Group	Ⅲ
Precautionary statements	P280-P305+P351+P338
UN Code	UN 2811

Certificate of Analysis

Lot Number